The present invention relates to stable sustained-release oral dosage forms of gabapentin, processes for preparation thereof, and uses thereof in treating epilepsy or post herpetic neuralgia.
STABLE SUSTAINED-RELEASE ORAL DOSAGE FORMS OF GABAPENTIN AND PROCESS FOR PREPARATION THEREOF